Last updated: Oct 30, 2026, 12:00 AM

Genmab AS Exchange (NASDAQ, USD)

GMAB

56.49
-0.80 (-1.40%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
93.92%
3 year return (CAGR)
24.15%
5 year return (CAGR)
4.02%
10 year return (CAGR)
13.08%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
35.25B
Price/Sales
8.53
Ent value
40.31B
Price/Book
5.92
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
44.73
PEG
-
Forward P/E
36.92
EPS growth
6.29%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open56.46
Daily high58.19
Daily low55.70
Daily Volume6.25M
All-time high57.29
1y analyst estimate39.05
Beta0.70
EPS (TTM)1.28
Dividend per share0.00
Ex-div date-
Next earnings date17 Feb 2026

Ready to capitalize on Genmab AS's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
GMABS&P500
Current price drop from All-time high-1.40%-1.25%
Highest price drop-84.20%-56.47%
Date of highest drop8 Aug 20119 Mar 2009
Avg drop from high-22.04%-10.65%
Avg time to new high21 days12 days
Max time to new high1292 days1805 days